The blind leading the blind: use and misuse of blinding in randomized controlled trials.

The use of blinding strengthens the credibility of randomized controlled trials (RCTs) by minimizing bias. However, there is confusion surrounding the definition of blinding as well as the terms single, double, and triple blind. It has been suggested that these terms should be discontinued due to their broad misinterpretation. We recommend that, instead of abandoning the use of these terms, explicit definitions of blinding should be adopted. We address herein the concept of blinding, propose standard definitions for the consistent use of these terms, and detail when different types of blinding should be utilized. Standardizing the definition of blinding and utilizing proper blinding methods will improve the quality and clarity of reporting in RCTs.

[1]  P. Gøtzsche,et al.  Blinding during data analysis and writing of manuscripts. , 1996, Controlled clinical trials.

[2]  D. Moher,et al.  Turning a blind eye:Testing the success of blinding and the CONSORT statement , 2004, BMJ : British Medical Journal.

[3]  G. Guyatt,et al.  Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.

[4]  David L Sackett,et al.  Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? , 2007, International journal of epidemiology.

[5]  Jafar Kolahi,et al.  Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. , 2009, Community dentistry and oral epidemiology.

[6]  T. Kaptchuk,et al.  Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine , 1998, Bulletin of the history of medicine.

[7]  D. Moher,et al.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.

[8]  F. Miller,et al.  Sham Surgery: An Ethical Analysis , 2003, The American journal of bioethics : AJOB.

[9]  P. Bossuyt,et al.  Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.

[10]  S. Senn Turning a blind eye: Authors have blinkered view of blinding , 2004, BMJ : British Medical Journal.

[11]  D. McCallie,et al.  Angina pectoris and the placebo effect. , 1979, The New England journal of medicine.

[12]  Henneicke-von Zepelin Hh Letter to the Editor [2] (multiple letters) , 2005 .

[13]  D. Moher,et al.  CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[14]  Duff Waring,et al.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials , 2004, BMJ : British Medical Journal.

[15]  J. Lonner,et al.  The ethics of sham surgery in clinical orthopaedic research. , 2007, The Journal of bone and joint surgery. American volume.

[16]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[17]  G. Guyatt,et al.  In the dark: the reporting of blinding status in randomized controlled trials. , 2002, Journal of clinical epidemiology.

[18]  D. Sackett Turning a blind eye:Why we don't test for blindness at the end of our trials , 2004, BMJ : British Medical Journal.

[19]  Heejung Bang,et al.  Assessment of blinding in clinical trials. , 2004, Controlled clinical trials.

[20]  Harri Hemilä,et al.  Assessment of blinding may be inappropriate after the trial. , 2005, Contemporary clinical trials.

[21]  I. Chalmers,et al.  The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.

[22]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[23]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[24]  T. Kaptchuk The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? , 2001, Journal of clinical epidemiology.

[25]  A. Hrõbjartsson,et al.  Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. , 2007, International journal of epidemiology.